Capturing the real‐world benefit of residual β‐cell function during clinically important time‐periods in established Type 1 diabetes

AIMS: Many individuals with type 1 diabetes retain residual β‐cell function, with increased endogenous insulin secretion associated with reduced hyperglycaemia, hypoglycaemia and glycaemic variability. However, it is unknown when these improvements occur during the day. Dysglycaemia is common in ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Guy S., Shaw, Andy C., Smith, Kieran, Wason, James, McDonald, Timothy J., Oram, Richard A., Stevenson, Emma, Shaw, James A. M., West, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research: Pathophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311680/
https://www.ncbi.nlm.nih.gov/pubmed/35181926
http://dx.doi.org/10.1111/dme.14814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311680/
https://www.ncbi.nlm.nih.gov/pubmed/35181926
http://dx.doi.org/10.1111/dme.14814

Ejemplares similares